Explore how COVID-19 accelerated the adoption of remote clinical management for rheumatic diseases, featuring digital tools, pilot studies, and future directions.
Exploring the safety of anti-TNF biologics for rheumatic patients with occult hepatitis B infection and evidence-based management strategies.